The Latest Breaking News from Crohn Disease

Kirsten said she had never had a medical condition up until her diagnosis in June 2021

‘Strictly Come Dancing’ star said she’s ‘gutted’ by recent events

Eli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising test results for a Crohn's treatment.

The incidence of Inflammatory Bowel Disease has almost doubled in India from 1990 to 2019, with rising death rate; lifestyle changes, a Westernised diet with high fat and high sugar, processed and packaged food have further increased incidence rates in India.

Dr. Gilles R.G. Monif's book on Crohn's Disease helps readers understand the disease, empowering them to break free from its harmful effects on both their health and finances.

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

Crohn’s disease affects four million people worldwide. The condition causes debilitating symptoms such as chronic fatigue, diarrhoea, abdominal pain, weight loss and malnutrition. Once symptoms develop, Crohn’s is a lifelong condition – and while there are ways to manage symptoms during flare-ups, there’s currently no cure.

A new study has highlighted the link between IBD, such as Crohn's disease and ulcerative colitis, and an increased risk of stroke in later life.